Paradigm Biocapital Advisors LP
Paradigm Biocapital Advisors LP reported 30 holdings worth US$5.03B as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Paradigm Biocapital Advisors LP reported 30 holdings worth US$5.03B as of Sep 30, 2026. Largest: Revolution Medicines, Inc., Genmab A/S and Edgewise Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 30
- Value as reported
- US$5.03B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Revolution Medicines, Inc. | 6.22M | US$1.28B | 25.4% |
| Genmab A/S | 14.1M | US$504M | 10.0% |
| Edgewise Therapeutics, Inc. | 10.8M | US$438M | 8.7% |
| Spyre Therapeutics, Inc. | 4.46M | US$397M | 7.9% |
| Insmed Incorporated | 2.7M | US$308M | 6.1% |
| MBX Biosciences, Inc. | 3.77M | US$221M | 4.4% |
| Oruka Therapeutics, Inc. | 2.49M | US$208M | 4.1% |
| Belite Bio, Inc. | 1.14M | US$194M | 3.9% |
| Tarsus Pharmaceuticals, Inc. | 2.3M | US$181M | 3.6% |
| Tango Therapeutics, Inc. | 6.96M | US$174M | 3.5% |
| Viridian Therapeutics, Inc. | 8.26M | US$170M | 3.4% |
| BridgeBio Pharma, Inc. | 2.35M | US$154M | 3.1% |
| Vaxcyte, Inc. | 2.14M | US$122M | 2.4% |
| Erasca, Inc. | 8M | US$117M | 2.3% |
| Jade Biosciences, Inc. | 6.05M | US$85M | 1.7% |
| Tyra Biosciences, Inc. | 3.51M | US$76.8M | 1.5% |
| Olema Pharmaceuticals, Inc. | 8.72M | US$75.3M | 1.5% |
| Obsidian Therapeutics, Inc. | 4.16M | US$57.1M | 1.1% |
| Structure Therapeutics, Inc. | 1.3M | US$40.6M | 0.81% |
| Achieve Life Sciences, Inc. | 4.95M | US$40.1M | 0.80% |
| Veradermics, Incorporated | 310K | US$37.6M | 0.75% |
| Assembly Biosciences, Inc. | 1.55M | US$36.5M | 0.73% |
| ORIC Pharmaceuticals, Inc. | 1.51M | US$20.3M | 0.40% |
| Editas Medicine, Inc. | 7.58M | US$19.5M | 0.39% |
| Hemab Therapeutics Holdings, Inc. | 629K | US$19.4M | 0.39% |
| Vor Biopharma Inc. | 890K | US$17M | 0.34% |
| Kardigan, Inc. | 900K | US$13.3M | 0.26% |
| TCGX Acquisition Corp. | 300K | US$3.75M | 0.07% |
| Inventiva SA | 808K | US$2.98M | 0.06% |
| Nuvalent, Inc. | 0 | US$0 | 0.00% |
| Alnylam Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Apogee Therapeutics, Inc. | 0 | US$0 | 0.00% |
| EyePoint, Inc. | 0 | US$0 | 0.00% |
| Lexeo Therapeutics, Inc. | 0 | US$0 | 0.00% |
| MapLight Therapeutics, Inc. | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC
Related